MP49-13 MANAGEMENT OF UROLOGIC CANCERS AT KCMC, TANZANIA: EXPERIENCE FROM A RESOURCE LIMITED SETTING

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP49-13 MANAGEMENT OF UROLOGIC CANCERS AT KCMC, TANZANIA: EXPERIENCE FROM A RESOURCE LIMITED SETTING Nicholaus Ngowi Bartholomeo, Harrison Gottlich, and Furaha Serventi Nicholaus Ngowi BartholomeoNicholaus Ngowi Bartholomeo More articles by this author , Harrison GottlichHarrison Gottlich More articles by this author , and Furaha ServentiFuraha Serventi More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003297.13AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Urologic cancers contribute to significant morbidity and mortality globally, despite being underestimated in most African countries. As the epidemiological transition continues, it will become even more important to properly screen, treat, and research them. Common urologic cancers (Table 1) treated at the Kilimanjaro Christian Medical Center (KCMC) center include prostate, bladder, renal, and Wilm’s tumor with management including surgical, endoscopic, and chemotherapy options. Radiation treatment is available by referral to Ocean Road Cancer institute and soon to be available at our center. KCMC continues to develop initiatives to improve patient outcomes for Urologic cancers in the Northern zone of Tanzania. METHODS: The center employed a community survey and screening using serum prostate specific antigen (PSA) among men aged 40 years and above to assess level of awareness and burden of prostate cancer (Pca) in northern Tanzania (catchment area of KCMC). Total serum PSA > 4 ng/mil was regarded as the critical value for tru cut biopsy of the prostate. Awareness was assessed using pretested questionnaire and categorized as poor (score < 50%) or good (score > 50%). In addition, after we obtained consent for all participants, more than 500 prostate tissue and about 6000 serum samples have been biobanked to investigate in genomic studies if there is a distinct mutation observed in these cancers contributing to late presentation. Lastly, the center recently broke ground on a radiation treatment building that will become another treatment option for our patients. RESULTS: The yet to be published cross-sectional study assessing burden and knowledge of Pca among at risk men in northern Tanzania showed a prevalence of Pca of 3% with most cases having intermediate risk disease based on Gleason score (Gleason score 7). Most respondents had poor knowledge and low perceived risk of Pca. CONCLUSIONS: Urological cancers are an important source of disease burden in developing countries like Tanzania, for which multi-modal approaches are needed to improve population health, including screening, community education, human and infrastructure investment, and basic science research. Source of Funding: PCF-Pfizer and CIRGO funded the assessment of prostate cancer awareness and burden in northern Tanzania © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e683 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nicholaus Ngowi Bartholomeo More articles by this author Harrison Gottlich More articles by this author Furaha Serventi More articles by this author Expand All Advertisement PDF downloadLoading ...